Concepedia

Vanessa Bolejack

VB

31

Publications

6.1K

Citations

26

H-Index

2003

Active since

Affiliations

Cancer Research And Biostatistics(Current)

Sarcoma Alliance for Research through Collaboration

University of Michigan

University of Arkansas for Medical Sciences

The University of Texas MD Anderson Cancer Center

Vanessa Bolejack is an author at Cancer Research And Biostatistics specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2022

31

Publications

31

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez, Aurélien de Reyniès, Emily Z. Keung et al. · Nature · 2020 · 1.8K citations · Full text

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

, , +5

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

Bart Barlogie, Elias Anaissie, Frits van Rhee et al. · British Journal of Haematology · 2007 · 325 citations · Full text

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan et al. · Journal of Clinical Oncology · 2019 · 251 citations · Full text

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

Heinz Ludwig, Brian G.M. Durie, Vanessa Bolejack et al. · Blood · 2008 · 232 citations · Full text

Rows per page

1–5 of 31